Skip to main content
. 2022 Jan 18;10(2):202. doi: 10.3390/biomedicines10020202

Figure 3.

Figure 3

The trends of pain and functional scores improvement during our treatment course at 1, 4, 12, 24, and 48 week (W). * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001 as compared with the data before treatment (PRE).